Notice Number: NOT-HL-19-709
Key Dates
Release Date: September 9, 2019
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
A pre-submission informational webinar for a suite of FOAs related to the NHLBI Catalyze Program is scheduled for October 3, 2019 at 12:00 pm EDT. The webinar will provide an overview of the Catalyze program and focus on the aforementioned RFAs. The webinar will outline the purpose and objectives of the Catalyze-related FOAs, including application and peer review requirements, and budget considerations.
The NHLBI Catalyze Program offers funding, technical services, training, and mentorship to help transform scientific discoveries into promising healthcare products, such as diagnostics, therapeutics, and devices. Supports product definition studies, preclinical research, and the development of cutting-edge platform technologies.
Early stage technology development funding will be available for:
- Therapeutics (Small molecules/Biologics)
- Identifying and characterizing lead compounds
- Devices/Diagnostics/Tools
- Developing, testing, and modifying prototypes
- Identifying and developing assay targets
- Developing research tools
- Enabling Technologies and Transformative Platforms
- Developing highly-innovative, next-generation technologies that could transform current approaches to clinical practice or translational research (technology must be beyond proof-of-concept and should be ready to begin validation)
- Accelerating the areas of early detection and screening, animal model development, or clinical diagnosis
Date and time: Thursday, October 3, 2019 at 12 pm EDT
Join Webex Meeting:
Event password: Catalyze
Audio Conference: (US/Canada):1-650-479-3208
Event Number (access code): 625 115 038
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e5721a56bfa66928d52f9c73fa2a72731
To Register in Advance:
Prospective applicants are invited to register in advance at the above address, and are strongly encouraged to send related questions to [email protected] at least 72 hours prior to the webinar.
See the Catalyze portion of the NHLBI website for additional information, including links to Frequently Asked Questions (FAQs) regarding the Catalyze-related RFAs. All applicants are encouraged to review the FAQs prior to both the webinar and submitting an application.
Inquiries
Please direct all inquiries to:
Kathleen Rousche, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Office of Translational Alliances and Coordination (OTAC)
Phone: 301 827-7981
Email: [email protected]
and Human Services (HHS)
